Clover Health Investments, Corp. CLOV
Set alert
4.46 USD -0.12 -2.62%
At close · Oct 30
4.46 0.00 0.00%
After hours · Oct 30, 7:57 PM ET
4.35 Day range 4.57
1.70 52-week range 5.41
- YTD
- +89.79%
- 1 year
- +28.53%
- Open
- 4.53
- Prev close
- 4.58
- Mkt cap
- 2.37B
- Vol
- 4.65M
- Avg vol
- 4.19M
- EPS
- -0.05
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.35
- High
- 4.57
- Forward P/E
- 29.73
- Beta
- 2.46
- Short ratio
- 5.73
- Inst. own
- 33.92%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 4.50
- 200-d avg
- 3.53
- 1y target
- 5.50
15m chart
Built from the cached five-day intraday bars.
Events in this range
- Oct 28, 2026Rating: Needham · — → Buy
Signals (20)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 2:55 PM | 1 day ago |
| SMA: Bearish | Oct 30, 2:10 PM | 1 day ago |
| MACD: Buy Signal | Oct 30, 1:25 PM | 1 day ago |
| RSI: Oversold | Oct 30, 12:55 PM | 1 day ago |
| RSI: Oversold | Oct 29, 3:55 PM | 2 days ago |
| SMA: Bullish | Oct 29, 1:10 PM | 2 days ago |
| SMA: Bearish | Oct 29, 9:40 AM | 2 days ago |
| SMA: Bearish | Oct 29, 9:40 AM | 2 days ago |
| SMA: Bullish | Oct 28, 3:40 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:40 PM | 3 days ago |
| SMA: Bearish | Oct 28, 3:25 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 12:40 PM | 3 days ago |
| SMA: Bearish | Oct 28, 11:55 AM | 3 days ago |
| RSI: Overbought | Oct 28, 9:40 AM | 3 days ago |
| MACD: Buy Signal | Oct 27, 2:40 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 12:40 PM | 4 days ago |
| SMA: Bearish | Oct 27, 11:55 AM | 4 days ago |
| SMA: Bullish | Oct 26, 3:55 PM | 5 days ago |
| SMA: Bearish | Oct 26, 3:25 PM | 5 days ago |
| SMA: Bullish | Oct 26, 3:10 PM | 5 days ago |
Key statistics
- Market cap
- 2.37B
- Enterprise value
- 2.19B
- Trailing P/E
- 0.00
- Forward P/E
- 29.73
- PEG ratio
- 0.00
- Price / sales
- 0.96
- Price / book
- 6.27
- EPS (TTM)
- -0.05
- Beta
- 2.46
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -0.74%
- Revenue (TTM)
- 2.48B
- Revenue growth
- 55.60%
- Free cash flow
- 69.05M
- Total cash
- 243.10M
- Total debt
- 0
- Return on equity
- -5.10%
- Shares outstanding
- 435.44M
- Short % of float
- 6.18%
- 50-day average
- 4.50
- 200-day average
- 3.53
Analyst view
Consensus: buy
Buy
Price target (mean) 5.50 +23.3% upside
Now 4.46
- Target (low)
- 5.00
- Target (mean)
- 5.50
- Target (high)
- 6.00
Ratings (0m) 5 3 buy · 2 hold · 0 sell
- Strong buy1
- Buy2
- Hold2
- Sell0
- Strong sell0
Next earnings
Nov 4, 2026
Expected Nov 4, 2026. Consensus EPS estimate 0.01.
Financials — quick view
CLOV Revenue — quarterly 743.17M
CLOV Net income — quarterly 28.00M
CLOV EPS — quarterly 0.05
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 4, 2026 | Sep 30, 2026 | -0.00507 | — | — | — |
| Aug 5, 2026 | Jun 30, 2026 | 0.03864 | 0.05 | +0.01 | +29.40% |
| May 6, 2026 | Mar 31, 2026 | 0.07 | 0.07 | 0.00 | 0.00% |
| Feb 26, 2026 | Dec 31, 2025 | -0.10212 | -0.05 | +0.05 | +51.04% |
| Nov 4, 2025 | Sep 30, 2025 | 0.02 | -0.05 | -0.07 | -350.00% |
| Aug 5, 2025 | Jun 30, 2025 | -0.00923 | -0.02 | -0.01 | -116.68% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 28, 2026 | Needham | init | — | Buy |
| Aug 6, 2026 | UBS | main | Neutral | Neutral |
| Jul 21, 2026 | Canaccord Genuity | main | Buy | Buy |
| Jun 11, 2026 | UBS | main | Neutral | Neutral |
| Jun 4, 2026 | Canaccord Genuity | main | Buy | Buy |
| Mar 20, 2026 | Canaccord Genuity | main | Buy | Buy |
About Clover Health Investments, Corp.
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Country
- United States
- Website
- cloverhealth.com
News
- This Kazia Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday
- This Rubrik Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday
- This Spero Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
- Needham Initiates Coverage On Clover Health Investments with Buy Rating, Announces Price Target of $6
- Clover Health to Participate in Upcoming UBS Global Healthcare Conference
- Clover Health Investments (NASDAQ:CLOV) Insider Karen Soares Sells 14,673 Shares of Company Stock
- Clover Health Investments (NASDAQ:CLOV) CEO Andrew Toy Sells 62,176 Shares of Stock
- Clover Health Investments (NASDAQ:CLOV) CEO Conrad Wai Sells 23,627 Shares of Stock
- Clover Health Earns Top Honors in U.S. News & World Report's 2027 Medicare Advantage Ratings Across Three States
- QUICK SPARK: UnitedHealth Calls 2026 the Bottom for Medicaid Margins
Your note
Sign in to keep a note on CLOV — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CLINTON CHELSEA | Director | Stock Award(Grant) | Jan 5, 2025 | 602,814 |
| GARIPALLI VIVEK | Director and Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Jan 6, 2026 | 1,856,250 |
| KOUZOUKAS DEMETRIOS L | Director | Stock Award(Grant) | Jan 5, 2026 | 605,980 |
| KUIPERS PETER J | Chief Financial Officer | Stock Award(Grant) | May 18, 2025 | 6,349,970 |
| PRIEST BRADY PATRICK | Officer | Sale | May 12, 2026 | 2,040,220 |
| REYNOSO JAMIE L. | Officer | Sale | Oct 18, 2026 | 2,770,350 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 8.06% | 35,106,965 | 156.58M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.14% | 18,037,661 | 80.45M | Jun 29, 2026 |
| Geode Capital Management, LLC | 2.49% | 10,846,066 | 48.37M | Jun 29, 2026 |
| State Street Corporation | 2.34% | 10,180,337 | 45.40M | Jun 29, 2026 |
| Nuveen, LLC | 1.44% | 6,291,699 | 28.06M | Jun 29, 2026 |
| Charles Schwab Investment Management, Inc. | 1.27% | 5,521,188 | 24.62M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.98% | 12,979,049 | 57.89M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.51% | 10,923,260 | 48.72M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.07% | 4,646,552 | 20.72M | Jun 29, 2026 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.06% | 4,600,368 | 20.52M | Jul 30, 2026 |
| iShares Trust-iShares Russell 2000 Growth ETF | 0.90% | 3,928,211 | 17.52M | Sep 29, 2026 |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 0.48% | 2,099,735 | 9.36M | May 30, 2026 |